Patent Assignment
Reel/Frame 070760/0864
Corrective Assignment to Correct the the Assignment Previously Recorded Previously Recorded at Reel: 068713 Frame: 0499. Assignor(S) Hereby Confirms the Assignment.
Recorded: 2024-10-24
Pages: 16
Assignee
PROVIDENT BANK
111 WOOD AVENUE SOUTH, SUITE 200, ISELIN, NEW JERSEY, 08830
Covered Properties
(17)
Pharmaceutical Composition Comprising (1R,4R)-6'-Fluoro-N,N-Dimethyl-4-Phenyl-4',9'-Dihydro-3'H-Spiro[Cyclohexane-1,1'-Pyrano-[3,4,B]Indol]-4-Amine and a Propionic Acid Derivative
Pharmaceutical Dosage Forms Comprising 6'-Fluoro-(N-Methyl- or N,N-Dimethyl-)-4-Phenyl-4',9'-Dihydro-3'H-Spiro[Cyclohexane-1,1'-Pyrano[3,4,b]Indol]-4-Amine
Process for the Preparation of 5-Fluorotryptophol
Cebranopadol for Treating Pain in Subjects with Impaired Hepatic and/or Impaired Renal Function
Titration of Cebranopadol
Extended Release Amphetamine Tablets
Patent:
11,590,081 →
Application:
16/139,251 →
Room Temperature Stable Oral Calcitonin Formulation
Extended Release Amphetamine Compositions
Patent:
11,590,228 →
Application:
16/376,638 →
Pharmaceutical Composition Comprising (1R,4R)-6'-Fluoro-N,N-Dimethyl-4-Phenyl-4',9'-Dihydro-3'H-Spiro [Cyclohexane-1,1'-Pyrano-[3,4,B]Indol]-4-Amine and Paracetamol or Propacetamol
Pharmaceutical Compositions Comprising a Floating Interpenetrating Polymer Network Forming System
Liquid Clonidine Extended Release Composition
Patent:
11,918,689 →
Application:
17/387,517 →
Benzonatate Modified Release Solid Tablets and Capsules
Patent:
11,938,224 →
Application:
17/406,137 →
Room Temperature Stable Oral Calcitonin Formulation
Modified Release Drug Powder Composition Comprising Gastro-Retentive Raft Forming Systems Having Trigger Pulse Drug Release
Application:
17/725,673 →
Publication:
US 2022/0241189
Oxybate Polyethylene Glycol Prodrugs
Application:
17/818,733 →
Publication:
US 2023/0110028
Extended Release Amphetamine Tablets
Liquid Clonidine Extended Release Composition
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 21, 2016
From: FROSCH, STEFANIE; LINZ, KLAUS; SCHIENE, KLAUS
To: GRUENENTHAL GMBH
Reel/Frame 038054/0297 →
Assignment of Assignor's Interest
Nov 1, 2016
From: PRUEHS, STEFAN; SCHAEFER, OLAF
To: GRUENENTHAL GMBH
Reel/Frame 040186/0435 →
Assignment of Assignor's Interest
Jun 11, 2018
From: FOREST LABORATORIES IRELAND LIMITED
To: GRUNENTHAL GMBH
Reel/Frame 046040/0689 →
Assignment of Assignor's Interest
Jun 11, 2018
From: BOINPALLY, RAMESH
To: FOREST LABORATORIES IRELAND LIMITED
Reel/Frame 046040/0038 →
Assignment of Assignor's Interest
Jun 11, 2018
From: KLEIDEITER, ELKE; CHRISTOPH, ANNETTE; FUSSEN, RENE; OSSIG, JOACHIM
To: GRÜNENTHAL GMBH
Reel/Frame 046039/0863 →
Assignment of Assignor's Interest
Apr 11, 2019
From: WANG, SHAONAN; PIANA, CHIARA; BURSI, ROBERTA
To: GRÜNENTHAL GMBH
Reel/Frame 048856/0890 →
Assignment of Assignor's Interest
Aug 16, 2019
From: DAGGS, THOMAS A.; SHIELDS, PAUL P.
To: ENTERIS BIOPHARMA, INC.
Reel/Frame 050072/0341 →
Assignment of Assignor's Interest
Aug 16, 2019
From: TARSA THERAPEUTICS, INC.
To: TAURUS DEVELOPMENT COMPANY LLC
Reel/Frame 050072/0425 →
Assignment of Assignor's Interest
Aug 16, 2019
From: GILLIGAN, JAMES P.; MAURER, GEORGE R.; RAILKAR, ANIRUDDHA M.; BAUER, PHIL
To: TARSA THERAPEUTICS, INC.
Reel/Frame 050072/0389 →
Security Interest
Aug 26, 2019
From: ENTERIS BIOPHARMA, INC.
To: CADENCE BANK, N.A.
Reel/Frame 050174/0428 →
Assignment of Assignor's Interest
Apr 1, 2020
From: MEHTA, KETAN; KATHALA, KALYAN; TU, YU-HSING
To: TRIS PHARMA, INC.
Reel/Frame 052280/0801 →
Assignment of Assignor's Interest
Sep 16, 2020
From: MEHTA, KETAN; KATHALA, KALYAN
To: TRIS PHARMA, INC.
Reel/Frame 053792/0128 →
Assignment of Assignor's Interest
Dec 10, 2020
From: JAIN, PARAS RAMESHLAL; CHAUDHARI, SACHIN VASANT
To: TRIS PHARMA, INC.
Reel/Frame 054676/0153 →
Assignment of Assignor's Interest
Aug 18, 2021
From: GRÜNENTHAL GMBH
To: PARK THERAPEUTICS, INC.
Reel/Frame 057212/0157 →
Assignment of Assignor's Interest
Oct 5, 2021
From: PATEL, GRISHMA
To: TRIS PHARMA, INC.
Reel/Frame 057707/0869 →
Assignment of Assignor's Interest
Feb 8, 2022
From: ANDREA NELSON; CHAUDHARI, SACHIN; JAIN, NEMICHAND B; PUTHLI, SHIVANAND
To: TRIS PHARMA, INC.
Reel/Frame 058965/0261 →
Assignment of Assignor's Interest
Feb 18, 2022
From: TARSA THERAPEUTICS, INC.
To: TAURUS DEVELOPMENT COMPANY LLC
Reel/Frame 059051/0340 →
Assignment of Assignor's Interest
Feb 18, 2022
From: DAGGS, THOMAS A.; SHIELDS, PAUL P.
To: ENTERIS BIOPHARMA, INC.
Reel/Frame 059051/0284 →
Assignment of Assignor's Interest
Feb 18, 2022
From: GILLIGAN, JAMES P.; MAURER, GEORGE R.; RAILKAR, ANIRUDDHA M.; BAUER, PHIL
To: TARSA THERAPEUTICS, INC.
Reel/Frame 059051/0297 →
Assignment of Assignor's Interest
Apr 22, 2022
From: JAIN, PARAS RAMESHLAL; CHAUDHARI, SACHIN VASANT
To: TRIS PHARMA, INC.
Reel/Frame 059684/0749 →
Assignment of Assignor's Interest
Jan 5, 2023
From: TAURUS DEVELOPMENT COMPANY LLC
To: PARK THERAPEUTICS, INC.
Reel/Frame 062287/0841 →
Release of Security Interest
Jun 28, 2023
From: CADENCE BANK, A MISSISSIPPI BANK AND SUCCESSOR BY MERGER TO CADENCE BANK, N.A., A NATIONAL BANKING ASSOCIATION, AS AGENT
To: ENTERIS BIOPHARMA, INC.
Reel/Frame 064149/0741 →
Assignment of Assignor's Interest
Sep 12, 2023
From: JAIN, PARAS R
To: TRIS PHARMA, INC.
Reel/Frame 064882/0900 →
Assignment of Assignor's Interest
Sep 18, 2023
From: JAIN, PARAS R; CHAUDHARI, SACHIN V
To: TRIS PHARMA, INC.
Reel/Frame 064941/0231 →
Assignment of Assignor's Interest
Feb 6, 2024
From: MEHTA, KETAN; KATHALA, KALYAN
To: TRIS PHARMA, INC.
Reel/Frame 066391/0117 →